Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Since symptoms don’t appear until the condition worsens, the only way to detect fatty liver early is through blood tests (LFT ...

A new study reveals that even low-dose, chronic exposure to air pollution can trigger liver inflammation, fibrosis, and metabolic disruptions, increasing the risk of fatty liver disease and other ...

Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, ...

A new model has projected a substantial rise in the burden of metabolic dysfunction-associated steatotic liver disease in the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver, and there are a number of ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues such as MASH.

These organizations can help you educate yourself, spread awareness, and connect with the MASH community to help you better ...

LiverRight™, a Cincinnati-based provider of healthcare services for the U.S. Hepatology and Fatty Liver Disease communities, announced today that the LiverRight Hepatology Clinic has begun treating ...